Effects of the COVID-19 pandemic on PV Strategy, Systems, and Processes of large, medium, and small companies – An Industry Survey
Our article, Effects of the COVID-19 pandemic on Pharmacovigilance strategy, systems, and processes of large, medium, and small companies – An industry survey, has been published in Volume 44 of the Clinical Therapeutics Journal.
The original research article, co-authored by subject matter experts from Tufts University School of Medicine, Pfizer, ResMed Limited, and Navitas Life Sciences presents the findings of a survey completed as part of Navitas Life Sciences’ industry leading pvnet and pvconnect networks.
Please complete the form to download the article abstract and learn more.
Published by Clinical Therapeutics | September 2022